Africa

REUTERS    by Emma Farge                                            Dec. 23, 2014

HASTINGS, Sierra Leone-- When Dr Sekou Kanneh goes to work at his Sierra Leonean Ebola clinic, he will probably be in the "red zone" for many hours, ignoring by necessity strict limits that govern foreign colleagues fighting the epidemic.

Doctor Sekou Kanneh speaks during an interview with Reuters TV in the Hastings ebola treatment centre at a neighbourhood in Freetown, December 21, 2014. Credit: Reuters/Baz Ratner 

Conditions at Kanneh's treatment center, the only Ebola unit in the country run by local staff, contrast to the purpose-built facilities where foreign volunteers who have flocked to Sierra Leone, Guinea and Liberia work.

Kanneh has received no official training to treat the virus that has killed over 7,000 people in West Africa. Still, he works up to four hour shifts in the stifling heat of the red zone, a ward where healthcare workers have direct contact with the highly contagious Ebola patients.

WORLD BANK PRESS RELEASE                                Dec. 22, 2014

The World Bank has approved a US$500,000 reallocation of existing development funds from on-going health and nutrition projects to support The Gambia prepare a plan in case of  a possible Ebola outbreak.

While there have been no reported cases of Ebola in The Gambia, its Ministry of Health and Social Welfare, working closely with the World Health Organization (WHO) and UNICEF, has nonetheless prepared a disease and Ebola preparedness plan.

 “The Ebola epidemic in neighboring countries has affected tourism in The Gambia as people are afraid to travel to and within Africa, resulting in great economic losses for the country,” said Vera Songwe, the World Bank Country Director for The Gambia. “We acknowledge that the virus is expanding both geographically and in the number of reported cases. The spread from Guinea to Mali highlights the escalating risk to regional security, stability and economic growth.

http://www.worldbank.org/en/news/press-release/2014/12/22/world-bank-the-gambia-ebola-prevention-plan

BBC     By Smitha Mundasad                                Dec. 22, 2014
The first-ever trial of an Ebola vaccine in Africa shows promising initial results, according to a report in the Lancet medical journal.

Scientists say it is a crucial step as other vaccines have shown lower levels of protection in African populations.

Tests involving Ugandan and American volunteers reveal the vaccine is so far safe and generates an immune response in both populations.

It provides reassurance for other trials currently underway, they say.

No proven vaccine exists to prevent people from getting the disease, though several trials are underway.

Researchers from the National Institutes of Health tested this experimental vaccine on healthy adults in Uganda, having first trialled it in the United States.

Dr Julie Ledgerwood, the lead researcher, said: "This is the first study to show comparable safety and immune response of an experimental Ebola vaccine in an African population.

Read complete story

http://www.bbc.com/news/health-30577776